医药公司已经开始对海底生物如海参下手，因为它可以为治疗癌症的药物提供材料。
Pharmaceutical companies are already mincing up Marine creatures known as sea cucumbers that may yet provide drugs for treating cancer.
如今的当务之急是能够保证这些孩子能够得到好的治疗。 如果人们认为这只是个生物学上的难题，他们就只会在生物学方面需找解决的方案----运用药物。
The important thing is making sure these kids get really good treatment.
但是直到目前他们还不能仿制复杂且昂贵的生物技术药物，这些药物越来越多的应用于治疗癌症、糖尿病和其它多发于像美国那样的富裕国家的疾病。
But they had never been able to copy the complex and expensive biotech medicines increasingly used to treat cancer, diabetes and other diseases in rich nations like the United States - until now.
现在则投向更个体化的药物，即更有效治疗小部分病患的生物技术药物。
Now they are investing in more personalised medicine: biotech drugs that treat small groups of patients more effectively.
他们给受保护的小鼠一到两种抗生素药物治疗，用低剂量来改变各种微生物的丰富性但不是杀死这些微生物。
They gave protected mice one of two antibiotic drugs in low doses that altered the abundance of various microbes but didn't kill the bugs.
目前神经生物学领域进行的睡眠对学习的作用的研究可能会给这些患者提供一些治疗药物。 这些药物将破坏完整睡眠中进行的记忆修复过程。
New insights into the neurobiology of sleep dependent learning may make it possible for these people to take a medication that disrupts this process while leaving restorative elements of sleep intact.
另外，在非肿瘤治疗领域，随着从分子生物学角度更好的理解疾病，对于特定靶点药物的研究有所增加。
Also, in nononcologic therapeutic areas understanding the molecular biology of the disease increases; thus, the chances of developing specific targeted drugs increase.
使用单一药物尤其是青蒿素及其衍生物的单一药物治疗疟疾可能会增加耐药性。
The likelihood of drug resistance is increased with the use of single-drug therapies for malaria, especially monotherapies of artemisinin and its derivatives.
药物作用是生物学目标性(治疗)的，是与事物的自然秩序相违背的。
Drug activity is biologically targeted and opposes the natural order of things.
阿米瑞斯生物技术公司开始运行时大规模使用也被称作合成生物技术的基因工程来培养能够制作治疗疟疾的药物的细菌。
Amyris started off using large-scale genetic engineering, also known as synthetic biology, to create bugs that make a malaria drug.
生物标记物用于衡量并预测某种癌症在治疗中是否对某种药物由应答。
A biomarker is something that can be measured to predict whether a particular cancer will respond to treatment with a particular drug.
发表在2007年11月的《美国实验生物学学会联合会杂志》上的新研究表示，下一代治疗癌症的药物或许将直接来自于天然的各类食品中。
The next cancer drug might come straight from the grocery store, according to new research published in the November 2007 issue of The FASEB Journal.
我们把该列表交给了大学，制药厂，生物科技公司，开始开发新的药物，因为这些突变基因及其蛋白质是新的治疗靶点。
We hand that list over to the universities, the pharmaceuticals, the biotech companies to start developing new drugs because those mutated genes and their proteins are targets for new therapeutics.
我们不是利用筛选过的化学制品治疗病人，而是从人体的细胞样本入手去了解人体生物学，然后据此研发药物的。
Instead of treating humans with chemicals, that are screened to become drugs, we actually started with human tissue samples and work to understand the biology and develop drugs based on that.
目的：探讨用ATP生物荧光肿瘤体外药敏检测技术（ATP-TCA）研究乳腺癌药物敏感性的异质性以及个体化治疗的可行性。
Objective:To investigate the heterogeneity of chemosensitivity in breast cancer using an ATP-tumor chemosensitivity assay (ATP-TCA) and the feasibility of individual chemotherapy.
根据细胞色素P 450和药物的生物转化来选择合适的药物及合适的剂量将有助于最大程度地提高药物治疗效应，同时减少药物不良反应和毒副作用。
Choosing the suitable drugs and dosages according to cytochrome P450 and drug metabolism would improve the pharmacotherapy efficacy and reduce the adverse drug reaction and toxic effect of drugs.
《中枢神经药物评论》3，第三号（1997）： 294-299，〈羟色胺受器研究的进展：分子生物学、信号传导和治疗学〉。
Martin, G. M. "Advances in Serotonin Receptor Research: Molecular Biology, Signal Transduction and Therapeutics. " CNS Drug Reviews 3, no. 3 (1997): 294-299.
据华东师范大学神经生物学教授林龙年介绍，这些研究大部分属于药物治疗。
According to Hua Dong biology of Normal University nerve teachs Lin long year the introduction, these research are belonged to for the most part medication.
方法：综合运用红外能量、磁场生物效应及药物导入三种治疗方法。
Methods the therapeutic techniques were designed including infrared energy, biological effect of magnetic fields and drug delivery.
孤儿药物包括药物或者生物制品，用于治疗疾病，并且在美国发病人数少于20万人。
Orphan drugs are either drug or biologic products used to treat diseases or conditions affecting fewer than 200,000 people in the United States.
因此，探索能高效传递药物和生物大分子进入中枢神经系统进行相应治疗的模式成为当前的重要课题。
Therefore, discovery of new modalities for effective delivery of drugs and biomacromolecules to the central nervous system is of great need and importance for treatment of neuropathy.
目前，对恶性骨肿瘤的治疗主要是以手术为核心，去除局部病灶，辅以化学药物、放射、生物学治疗的全面综合性治疗。
Currently, the therapy for bone sarcoma is mainly removing the local lesion through surgery, cooperated with auxiliary treatments of system chemicals, local radiation or bio-therapy.
综述了难治性精神分裂症的生物学因素、药物治疗和非药物治疗方面的进展，为临床治疗提供理论指导。
In this article, the author reviewed biological factors, drug treatment and non - drug treatment of the treatment resistant schizophrenia, and provided theoretical guidance for clinical treatment.
目的呼吁严格限制抗微生物药物用于治疗非感染性疾病。
OBJECTIVE To appeal for restricting strictly the application of antibiotics in treating non-infective disease.
但是一个关于高血压药物治疗的讨论不仅包括生物化学和药理学还包括医疗费用和医疗结果的研究。
But a discussion about a new group of high blood pressure medications can include not only biochemistry and pharmacology but also health care costs and outcomes research.
这些被抑制和被激活的蛋白可能为肿瘤生物标志物和药物作用靶点，为肿瘤的诊断和治疗提供了新的候选蛋白。
These repressed or activated proteins were the potential tumor biomarkers and drug targets, which would offer the candidate proteins for tumor diagnosis and treatments.
选择性COX - 2抑制剂可联合化疗、内分泌治疗及生物治疗等，作为肿瘤治疗的辅助药物应用于临床，为乳腺癌的治疗提供一种新的途径。
Selective COX-2 inhibitors can combine with chemotherapy, endocrine therapy and biotherapy. It is gradually used for adjunctive therapy and provides a new pathway for the therapy of breast cancer.
结论：抗精神病药物的神经生物学作用机制可能是一种通过药物作用的“基因治疗”方法。
CONCLUSION: the neurobiological mechanism of antipsychotic drugs may be a method of gene therapy through the effect of drugs.
手术治疗、放射治疗、化学药物治疗、生物免疫治疗是目前癌症的四大治疗手段。
Operation treatment, radiotherapy, chemical medication, biological immunization therapy are four major treatment means of the cancer at present.
手术治疗、放射治疗、化学药物治疗、生物免疫治疗是目前癌症的四大治疗手段。
Operation treatment, radiotherapy, chemical medication, biological immunization therapy are four major treatment means of the cancer at present.
应用推荐